Catherine Paterson
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
Paterson, Catherine; Kennedy, Catriona
Abstract
Prostatitis is a common condition which can affect men of all ages; however, it is more frequently experienced in younger men with an initial onset around 40 years of age. The two main presenting clinical features of prostatitis are lower urinary tract symptoms and pelvic pain. Other symptoms might include obstructive or irritative voiding symptoms, ejaculatory pain, and hematospermia. A diagnosis is usually based on the man's history, physical examination, urinalysis, and the two-or four-glass test (also known as obtaining urine specimens before, during, and after prostatic massage). Further investigations may also be performed when considering the differential diagnosis. Prostatitis can result in a significant reduction in quality of life (QOL) and pain can be associated with sexual dysfunction in men. Prostatitis can be classified as four distinct types, namely, type I acute prostatitis, type II chronic bacterial prostatitis, type III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and type IV asymptomatic prostatitis. It is unclear whether type III can be linked in all cases to prostatic involvement therefore the alternate denomination CPPS is used in clinical practice. Furthermore, CP/CPPS is further subclassified as type IIIa (inflammatory), and type IIIb (noninflammatory) which is dependent on the presence of inflammatory cells in prostatic secretions. CP/CPPS is considered when pelvic pain is present for at least three of the preceding 6 months with no other identifiable causes determined. There are several hypothesized causes of CP/CPPS which include: neuropsychological factors, infection, inflammation/autoimmunity, and dyssynergia voiding associated with bladder neck hypertrophy. Given the wide range of potential causes of CP/CPPS, there are many pharmacological interventions available in clinical practice to manage this complex condition. It is important to critically summarize evidence-based recommendations to inform the clinical management of men affected by CP/CPPS (Franco et al., 2019).
Citation
PATERSON, C. and KENNEDY, C. 2020. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Research in nursing and health [online], 43(5), pages 548-549. Available from: https://doi.org/10.1002/nur.22027
Journal Article Type | Review |
---|---|
Acceptance Date | Apr 28, 2020 |
Online Publication Date | May 20, 2020 |
Publication Date | Sep 30, 2020 |
Deposit Date | Jun 15, 2020 |
Publicly Available Date | May 21, 2021 |
Journal | Research in nursing and health |
Print ISSN | 0160-6891 |
Electronic ISSN | 1098-240X |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 43 |
Issue | 5 |
Pages | 548-549 |
Item Discussed | FRANCO, J.V.A., TURK, T., JUNG, J.H., XIAO, Y.-T., IAKHNO, S. TIRAPEGUI, F.I., GARROTE, V. and VIETTO, V. 2019. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane database of systematic reviews, 10, artic |
DOI | https://doi.org/10.1002/nur.22027 |
Keywords | Prostatitis; Men; Lower urinary tract; Pelvic pain; Pharmacological therapies; Sexual dysfunction; Quality of life; Depression |
Public URL | https://rgu-repository.worktribe.com/output/929983 |
Files
PATERSON 2020 Pharmacological interventions
(313 Kb)
PDF
You might also like
Towards resilience: examining complex and hybridised coping strategies used by NHS workers experiencing long COVID illness.
(2023)
Presentation / Conference
Downloadable Citations
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search